Skip to content

Clinical trials

Fatty Liver trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: Germany Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20083
20091
20101
20111
20122
20153
20171
20181
20191
20201
20213
20232
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting6
Active, not recruiting3
Terminated3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
German Diabetes Center2
Sanofi2
Abbott1
AstraZeneca1
Eli Lilly and Company1
Enanta Pharmaceuticals, Inc1
Endra Lifesciences1
Galmed Research and Development, Ltd.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver25
Non-alcoholic Fatty Liver Disease17
Fibrosis6
Liver Cirrhosis6
Diabetes Mellitus, Type 25
Liver Diseases4
Obesity4
Digestive System Diseases3
Insulin Resistance3
Diabetes Mellitus2

Trials

Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.